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Seasonality and Prevalence of Respiratory Syncytial Virus in Kinshasa, Democratic 
Republic of Congo. 
Kapandji Kasenga Merveille 
Graduate School of Public Health 
Yonsei University 
 (Directed by Professor Tai-Soon Yong) 
The Democratic Republic of Congo (DRC) with its tropical climate in the past was 
thought not to house many respiratory viruses, with time and after many outbreaks began 
researches and surveillance on respiratory viruses circulating in the country. The first was 
influenza sentinel surveillance which showed that around 10% of suspected samples 
received were positive for influenza and 90% were negative, therefore a research was 
needed to find which other virus was present and causing infection in the remaining 90%. 
This study aimed to screen Respiratory Syncytial Virus (RSV) among those remaining 
samples in Kinshasa in order to determine the proportion and seasonal factors influencing 
the virus.  
The samples used were nasopharyngeal swabs collected from different Influenza 
surveillance sites in Kinshasa: Kalembelembe, Boyambi, Kinshasa General Hospital, 
Kingasani Hospital Centre and RVA clinic during the period of January to September 
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2016. 169 Samples were randomly selected for the research and were chosen regardless 
of the patient’s age, sex, geographic group and symptoms. Molecular analysis was done 
to determine if the samples were RSV positive or negative at the National Reference 
Laboratory (NRL) in Kinshasa using real time reverse transcription-polymerase chain 
reaction (rRT-PCR). 
13.6% were positive for RSV. The prevalence was higher in female 65.2% than in 
male 34.8%, over 95% of RSV infection occurred during the rainy season and among the 
positive cases 60.9% were from hospitalized patients with severe acute respiratory 
infection and 39.1% were from influenza-like illness or infection. The largest proportion 
(78.3%) of RSV positives was found in children under the age of 2 years.  
This study showed that RSV is found in Kinshasa, DRC at most during the rainy 
season and tend to fade away during the dry season. Children are the most affected 
especially those younger than 2 years and RSV was more prevalent in female than in 
male. 
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Respiratory Syncytial Virus (RSV) in many countries has shown to be responsible 
for many respiratory tract infections in children (Troeger, et al, 2018). The viral pathogen 
causes both upper respiratory tract infection (URTI) and lower respiratory tract infection 
(LRTI) in children and in adults. The infection in adults is usually mild and less severe 
than in children, unless the adult has an immunocompromised health issue or/and 
cardiovascular problems (Kelsey, et al, 2018). It is the most common cause of pneumonia 
and bronchiolitis in children (Dearden, et al, 2018). In children, RSV is the most common 
viral cause of respiratory tract infection especially in children younger than 5 years old 
and it is the viral leading cause of children hospital visits, hospitalization and death 
resulting from to respiratory tract infections (Scheltema, et al, 2017). 
The average hospital length for RSV infection is 3 days in uncomplicated cases 
and increases with the severity of the infection causing a challenge for hospital services 
as it requires a lot both in human resources and in provision of medicines and care 
especially during RSV seasonal peak. But it also a financial burden for the families that 
have to stay longer at the hospital or often visit the hospital due to RSV infections (Shi, et 
al, 2017; Madhi, et al, 2003). 
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Worldwide RSV has been and remains a major public health problem as it poses a 
high burden on health system both in developed countries and in developing countries. In 
the 2005 report of the global overview of RSV burden, it appeared that RSV was the most 
viral pathogen causing severe acute lower respiratory infection as it was associated with 
22% of severe acute LRTI. Around 55 000 to 199 000 of deaths that occurred in children 
younger than 5 years old in 2005 were caused by RSV (Nair, et al, 2010). In the year 
2015, the new global report and estimates on RSV burden showed that RSV caused 31.1 
million acute lower respiratory tract infection (ALRTI) and from those infections 3.2 
million resulted in hospitalization with 59 600 deaths in children younger than 5 years. 
The report also showed that number of deaths caused by RSV ARLI moved from 28% in 
2005 to 5% in 2015 (Shi, et al, 2017). Nonetheless RSV still is a major burden worldwide 
especially in developing countries and to date continues to weight on people’s health and 
health system around the world. 
Overall 60 to 70% of all children in the world have been infected by RSV by the 
age of 2 years and 2-3% of those resulted in hospitalization (Stein, et al, 2016). Children 
that have been infected by RSV within their early life have shown to develop recurrent 
wheezing and asthma during childhood (Obando, et al, 2018). 
The diagnosis of RSV is mostly based on clinical symptoms. Among those 
symptoms are runny nose, fever, nasal congestion, cough wheezing, chest congestion, 
difficult breathing. Besides, the clinical symptoms based diagnosis, other diagnostic 
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method are used such as viral culture, rapid antigen detection tests and reverse-
transcriptase polymerase chain reaction (Griffiths, et al, 2017). 
Currently there is no official effective cure for RSV; the treatment is based on 
supportive care by treating the symptoms or giving oxygen therapy in severe cases 
making it difficult for broken health system and facilities that do not have the proper 
resources (Ferolla, et al, 2019). There is no vaccine for RSV at the moment but candidate 
vaccines are being studied (Lee, et al, 2017). Palivizumab is given as a preventive 
measure for RSV high risk people such as premature babies, people with 
cardiopulmonary and cardiovascular diseases as well as immunocompromised 
individuals, but the process is highly costly and not easily accessible (Dearden, et al, 
2018). Nevertheless, many new strategies are being studied to find a cure to RSV.  
The more there are researches to find cures against RSV, the more there is a need 
for accurate data regarding RSV epidemiology worldwide but there is still a lack of 
knowledge in many areas of RSV, lack of data especially in high burden countries like 
developing countries and this allows RSV to remain a big problem (WHO, 2016). Lack of 
data on RSV makes the viral pathogen a major public health problem (Sanicas, et al, 
2016) because there is a high need for more epidemiological studies and established RSV 
surveillance especially in developing countries in order to perfect RSV prevention, 
diagnostic measures and treatment. Therefore, data on the timing and prevalence of the 
virus should be available in every country to provide a good knowledge on the viral 
pathogen and infection. With that being said, more researches should be directed toward 
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describing the epidemiology in countries that doesn’t have data on RSV (Obando, et al, 
2018). This research study on seasonality and prevalence of RSV in Kinshasa, DRC 
which is the first ever laboratory confirmed RSV study done in Kinshasa the capital city 
and province of the Democratic Republic of Congo (DRC) may contribute in resolving 
the issue of data unavailability on RSV incidence in Kinshasa, DRC. As it is important to 
know the pattern of RSV to efficiently treat it, this first study may provide some of the 
necessary information needed in order to have a picture and representation of the 
circulation of RSV in Kinshasa, DRC. 
 
1.2.  Literature review 
In public health, RSV infection is an important burden as it is globally epidemic 
and is associated with high mortality and morbidity in developed and developing 
countries (Abraha, et al, 2015). RSV causes seasonal epidemics every year all over the 
world, making children and adults sick, but mostly children and causes severe infections 
in children younger than 5 years old. RSV has a very high mortality and morbidity rate in 
young children. By the age of 2 years old every child has been infected with RSV. 
Literature comes from researches and studies done on RSV seasonality, prevalence, RSV 
surveillance, burden and global estimates. Not all countries have RSV surveillance hence 
the lack of data in many countries; some countries have inserted RSV within their 
influenza surveillance and surveillance of other respiratory viruses (Obando, et al, 2018). 
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Ali, 2012 stated that RSV mostly causes infection in children younger than 2 years of 
age.  
In the literatures, incidence of RSV infections appeared to be lower in Asian 
countries than in African countries and 70% RSV infection, death and burden was found 
in developing countries in children 1 month to 5 years. In Africa, most LRTI were found 
to be caused by RSV (Sricharoenchai, et al, 2016). In a study done in 2013 in African 
countries, it was found that the largest percentage of death from pneumonia within a 
period of 3 years was caused by RSV; for example, in Kenya whereby the prevalence for 
RSV positive was 12.5% (Ahmed, et al, 2012). RSV has shown to affect people from all 
ages, sex, cultural background, socioeconomic status and demographics. Some studies 
have shown that RSV could infect the same person more than once as reinfection was 
observed each year with rate between 6% and 83% which goes to show that an initial 
infection from RSV does not provide immunity for upcoming infections (Tregoning, et al, 
2010) 
The risk factors that increases the chance of RSV infection are temperatures and 
seasonal factors, age, sex in some studies, prematurity, low weight at birth, having 
siblings, overcrowded houses, working with children, compromised immune system, 
cardiopulmonary diseases and cardiovascular diseases (Kelsey, et al, 2018; Stein, et al, 
2016). Rahman, et al, 2014 found no significant association between RSV incidence and 
gender, race, specimen and symptoms but a significant association with age group of a p 
value of  p <0.001 
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In age, it has already been said that RSV causes a high under 5 year old mortality 
and causes high number of hospitalization and hospital visits, but also does affect older 
children and adults although it causes milder infections and wears off quickly, it may in 
favourable circumstances cause more serious infections (Falsey, et al, 2000). There isn’t 
much literature and studies on infection of RSV in adults, therefore the pathophysiology 
is not well known, but the few studies done show that it is most commonly found in 
immunocompromised adults and suggest that the smaller airways in children and smaller 
maternal immunity are the reasons why children are the most affected (Loubet, et al, 
2016).  
When it comes to gender many studies suggest that RSV can be more prevalent in 
one gender than the other, but those results are most of the time not statistically 
significant and usually biased especially when the number of sample is not taken equally 
in both gender (Salimi, et al, 2015; Rahman, et al, 2014). In Biko Hospital study the 
findings showed that RSV incidence was greater in male gender children than in female 
but they did not count it as a risk factor (Dearden, et al, 2018). Another study had the 
same findings but also found that more male coming from overcrowded houses were 
positive for RSV and more female that were not breastfed were positive for RSV which 
makes breastfeeding a protective factor from RSV (Ferolla, et al, 2019).  
RSV seasonality varies globally and differs from one country to another. Countries 
that have an RSV surveillance system show more variation in RSV season and countries 
with no RSV surveillance show less variation in RSV season due to lack of data. 
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Preventive measures could be considered useless due to the major seasonal variation that 
may occasionally occur within countries; therefore a strong surveillance system is 
recommended (Obando, et al, 2018). Past Studies revealed that in temperate climate 
regions and countries like Europe and North America RSV followed the decrease in the 
temperature meaning RSV was more prevalent during the cold season or winter; 
However, in tropical and sub-tropical climate regions that have a lot of rain, RSV was 
mostly found during the rainy wet season, which is the result expected for Kinshasa DRC 
as it is found in the tropical climate region. In countries near the Equator like 
Mozambique and Malaysia, which have a heavily rainy humid season; RSV tend to go up 
to 10 months (Robertson, et al, 2004; Khor, et al, 2012). Countries like Brazil, Australia 
and USA which cover large territories and have more than one climatic region showed 
different intercountry RSV seasonality (Freitas, et al, 2016; Australia Gov, CDC); Since 
DRC also covers a very large territory and comprises more than one climatic region, 
same results are expected.  
Paynter, et al, 2014 found a direct association between environmental factors and 
presence of RSV and for a seasonal RSV outbreak to occur. Because of the way the 
environment influences viral transmission, environment was stated to play a big role in 
the maintenance of RSV seasonality by influencing viral transmission during a specific 
period of time. Literature showed that RSV throughout the year occurs in seasons 
depending on the climate of regions, hemisphere and equatorial proximities (Ferolla, et 
al, 2013).  
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Currently there is no data available on RSV in Kinshasa, DRC and as mentioned 
above data availability is important for any given public health burden disease or 
infection such as RSV infection. Therefore a research study on RSV in Kinshasa, DRC 
was needed to fill the gap in information and to provide data. This could be done by 
firstly finding the proportion of RSV in Kinshasa, DRC then look at the seasonal factors 
and influences on RSV incidence in Kinshasa, DRC. Another reason why this study was 
conducted was to find which other respiratory virus besides Influenza was circulating and 
infecting people as the above question was raised after the first influenza research and 
sentinel surveillance in DRC revealed that out of all the samples screened for Influenza 
virus in Kinshasa only 15% were positive for Influenza virus in Kinshasa, and 9% 
country-wise; with that came the need to conduct researches on the remaining negative 
samples to find if other respiratory viruses could be present. Due to RSV public health 
burden and importance worldwide, it was only fair to firstly screen those remaining 
negative samples for the presence of RSV in the national influenza reference laboratory 
(NIRL) (Kavunga, et al, 2018; Nkwembe, et al, 2017; Muyembe, et al, 2012).  
There are many callings in literatures of respiratory tract infections. In this study 
the terms used are influenza-like illness (ILI) and severe acute respiratory infection 
(SARI) taking notes that all SARI patients are hospitalized or in patients. Both terms are 




1.3.  Study Goal 
This study aimed to investigate RSV incidence in Kinshasa, DRC in order to find 
and state the proportion of RSV occurrence as well as the seasonal factors influencing 
Respiratory Syncytial Virus in Kinshasa DRC. 
1.4. Study Objectives 
1) Determine the prevalence of respiratory Syncytial virus circulating in Kinshasa 
DRC. 
2) Determine the seasonal factors influencing respiratory Syncytial virus prevalence 
in Kinshasa DRC. 
1.5. Study Question  
What is the prevalence and seasonal factors influencing RSV in Kinshasa province 
of the Democratic Republic of Congo?  
1.6. Hypothesis 
1) Respiratory Syncytial Virus presence in Kinshasa, DRC could be affected by 
socio-demographic characteristics such as gender, age and also severity of 
infection and hospitalization. 
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2) Respiratory Syncytial Virus incidence could be different according to the rainy 



















2.1 Study Design 
A cross sectional study is a study that analyses data or representation of a 
population at a specific point of time whereby both the exposure and the outcome are 
measured at the same time. An Analytical cross sectional study is a study that analyses or 
determines the health outcome from an exposure and data from exposure and health 
outcome are selected and analyzed to compare the results and determine the prevalence of 
a health condition (Setia, 2016). 
This research study design is analytical quantitative cross sectional study to 
determine the prevalence as well as the seasonality of RSV in Kinshasa, DRC by finding 
the proportion of RSV found in nasopharyngeal swabs from samples collected from 
January to September 2016 in Kinshasa, DRC and analyzed in the NIRL of the national 
institute of biomedical research (INRB) in Kinshasa during the year 2017 using 
secondary data. 
 
2.2. Target population 
The population used for this study was taken from the in and out patients of the 
hospitals that were part of the influenza sentinel surveillance project. The sentinel sites 
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chosen were both public or private clinics and hospitals in Kinshasa, DRC: RVA clinic, 
Boyambi Clinic, Kalembelembe Pediatric Hospital, Kinshasa General Reference Hospital 
and Kingasani Hospital Center (See Table 2.1 for characteristics of sentinel sites). The 
chosen sites demographically represented the population of Kinshasa as they received 
patients from all parts of the province. The criteria used for choosing the 5 sentinel sites 
were a higher accessibility, higher affordability for all patients including free and low 
cost services, higher number of qualified personnel, attendance of 50% on urban area and 
30% on rural area, have good storage and a cold chain which is crucial when dealing with 
respiratory viruses and have the ability to easily ship samples to the laboratory. The 
medical staffs at the sentinel sites were trained to recognize patients that met the case 
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2.3. Case definition 
The case definition was patient that presented with influenza-like illness (ILI) or 
showed signs of Severe Acute Respiratory Infection (SARI). ILI patient’s symptoms were 
sudden onset of fever with a temperature of ≥38°C accompanied by cough or sore throat 
and the SARI patients were all hospitalized patients with or without fever accompanied 
by cough and difficulty in breathing plus one or more of the following symptoms: 
vomiting, unconsciousness, lethargy, convulsion and shortness of breath within the past 7 
days (Ortiz, et al, 2009).   
The specimens collected from patients with the patient’s permission and 
acknowledgement of the research process were nasopharyngeal swabs that were obtained 
by having the patient’s head tilted back at 70˚ angle then inserting a swab at the back of 
the throat or nose for a few seconds then take it out, the swab was then put in a cryovial 
tube containing 3ml of universal transport medium (UTM) and was kept at a temperature 
of 4-8˚C within the sentinel sites before it could be shipped to the laboratory for analysis. 
Later on the nasopharyngeal swabs were sent to the national reference laboratory in 






2.4. Laboratory analysis 
The samples came to the INRB and were analyzed in the NIRL located inside the 
INRB. Upon reception, the samples were first registered and given a reference number, 
then divided into 3 aliquots by transferring 1ml of samples respectively in 3 different 
eppendorf tubes, the tubes were then kept frozen at -80˚C before being analyzed for 
detection of RSV in the laboratory. The laboratory analysis done for detection of RSV 
was firstly extraction of nucleic acid material and secondly the identification of the virus 
by Polymerase Chain Reaction (PCR). Respiratory virus nucleic acid material is RNA, 
not DNA, therefore it was needed to do a reverse transcription PCR from RNA to DNA 
and the reference laboratory in Kinshasa INRB is to date the only laboratory in the 
Democratic Republic of Congo capable of detecting respiratory tract viruses using real-
time reverse-transcription polymerase chain reaction assay (rRt-PCR assay).         
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2.4.1. RNA extraction 
The extraction of the viral RNA was done using QIAamp Viral mini kit (Qiagen) 
following the Qiagen kit protocol. The kit contained:  
 Quick-Start Protocol 
 QIAamp mini spin columns 
 Carrier RNA (Poly A) 
 Buffer AVL 
 QIAGEN® Proteinase K 
 Buffer AW1 (concentrate) 
 Buffer AW2 (concentrate) 
 Buffer AVE 
The viral RNA extraction or purification was done by following the Qiagen kit 
protocol following steps: lyses of the cellular material, precipitation of the nucleic acid 
material, adsorption and purification of the nucleic acid material.  
 
2.4.2. Amplification 
The purified RNA was amplified using the ABI 7500 Fast Ambion Applied 
Biosystems AgPath One-Step real-time reverse-transcription polymerase chain reaction 
assay (rRt-PCR assay) to screen for the presence of Respiratory Syncytial virus (RSV). 
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As stated before the NIRL in INRB to date is the only laboratory in DRC that is capable 
to perform Respiratory virus diagnostic using rRt-PCR assay and has met the standards of 
the External Quality Assessment Program (EQAP) administered by the WHO. Table 2.2 
provides a description of the rRT-PCR machine set up including the different stages, 
number of cycles, temperature and time.  
 
Table 2.2. Amplification Information 
Stages  Cycle  Temperature  Time  
Denaturation  1  45 °C  10 minutes  
Annealing 1  95 °C  10 minutes  
Elongation 45  95 °C  15 seconds  







2.5. Outcome and Statistical Analysis  
The outcome of this study was laboratory confirmed presence of RSV in the 
nasopharyngeal swabs of the study participants representing the population of Kinshasa 
in the Democratic Republic of Congo. The Statistical analysis was performed using the 
SPSS 25. A 95% confidence interval (CI) odds ratio was done to determine the 
association between the outcome and exposure. The statistical significance for this study 
















Out of the 169 samples that were analyzed, 23 cases (13.6%) of the 
nasopharyngeal swabs were positive for respiratory syncytial virus and 146 samples were 
negative for RSV. Out of the 23 RSV positive samples, 8 (34.8%) positives samples were 
from male patients and 15 (65.2%) were female patients, 22 (95.7%) of RSV incidence 
occurred during the rainy season and 1 (4.3%) was found during the dry season. 18 
(72.3%) out of the 23 samples positive for RSV were children between the age of zero 
and two and the denominator for age was 0-2 years following literatures and results from 
RSV researches around the world. According to the severity of the RSV infection, 60.9% 
of RSV positives were from hospitalized patient with severe acute respiratory infection 
and the 39.1% remaining were from patients suffering from influenza-like illness.  
 
3.2. RSV Prevalence by age 
In this study, 18 out of 23 RSV positive samples were from children between ages 
zero to two which was the denominator age for the study, as age increased RSV incidence 
decreased. One RSV positive sample was from a 6 years old patient, 2 RSV positives 
samples came from an 11 years old patient and a 25 years old patient and the remaining 2 
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RSV positive samples were from patients older than 40 years. Table 3.1 shows the 
average age for RSV incidence in Kinshasa, DRC including the standard deviation and 
the range. 
 
Table 3.1 RSV distribution by age 
RSV Outcome Age 
Mean STD Lowest* Oldest 
RSV Positive 
sample 
6.3 13.2 < 12 months 46 
RSV Negative 
sample 
18.3 21.5 < 12 months 71 
  * Lowest age: sample from patient younger than 12 months. 
 
3.3 RSV Outcome by Gender 
When it comes to gender, out of the 79 male and 90 female that participated in this 
study RSV was more prevalent in female than in men as seen in figure 3.1 and the 
statistical analysis shows that the association between gender and the presence of RSV 
was not statistically significant therefore stating that RSV incidence is not affected by 
gender. (Table 3.2)  
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3.4 RSV Seasonality 
RSV positive samples in this study were unevenly distributed throughout the year 
between the two seasons found in Kinshasa, DRC which are the dry season that goes 
from June to September and the rainy season that goes from October to May in Kinshasa 
from the findings in this study. In Figure 3.2 which describes the distribution of RSV in 
the months of January to September 2016, it shows that January, February and March had 
the most occurrence of RSV with six RSV positive samples found respectively, followed 
by the months of April and May which had two RSV positive samples and lastly the 





Figure 3.1 Distribution of RSV by sex 
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which is considered the cold season in DR Congo meaning June to September there were 
little to no positive sample during those months. 
 
        
 
3.5. RSV prevalence by case severity SARI and ILI 
In this study the severity of infection was stated by whether patients from which 
the samples were taken had severe acute respiratory infection (SARI) and were 
hospitalized or had a milder infection which was an influenza-like illness (ILI). RSV 
findings showed that out of the 75 enrolled SARI and 94 enrolled ILI in this study, RSV 
was more prevalent in SARI samples and less prevalent in ILI samples. (Figure 3.3) 


























3.6. Data Analysis 
As seen in the statistical analysis test table 3.2 children less than 2 years of age are 
less likely to be negative for RSV with an odds ratio of 0.149 and a confidence interval of 
0.052-0.425 which is statistically significant. People in the dry season are more likely to 
be negative for RSV with an odds ratio of 23.230 and a confidence interval of 3.053 and 
176.960 which is statistically significant. Females are more likely to be negative for RSV 
with an Odds ratio of 0.563 and a confidence interval of 0.225 and 1.410 which is not 





Figure 3.3 Distribution of RSV by case 
severity SARI and ILI 
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more likely to be negative for RSV with an Odds ratio of 0.461 and a confidence interval 
of 0.188 and 1.134 which is not statistically significant.  
 
3.7. PCR Value 
PCR machine value comes from the machine and is called Cycle Threshold (CT), 
the cycle threshold is the highest amplification cycle from which the virus reaches its 
threshold, at that moment the nucleic material of the virus can no longer be amplified, it 
varies between samples and depends on the viral load of the sample, the larger the viral 
load the lower the CT would be and the lower the viral load the bigger the cycle threshold 
will be. Whenever there is no amplification, meaning the sample does not contain any 
virus, the machine would not give out a CT and say the CT is undetected (UD). Table 3.3 
shows the CT of all of the 23 RSV positive samples and table 3.4 shows the average CT 








Table 3.2 RSV Outcome and odds ratio finding 
Variables RSV Outcome  Odds 
ratio 
95% CI 




Age 0-2*(n=69) 51 18 0.149 0.052 0.425 
Other(n=100) 95 5  




Season Dry(n=76) 75 1 23.23 3.052 176.960 
Rainy(n=93) 71 22 
Severity SARI(n=75) 61 14 0.461 0.188 1.134 
ILI(n=94) 85 9 
 *Reference age for comparison of RSV incidence by age according to general results 






















16GP0011 18 32 UD 
16GP0013 24 32 UD 
16GP0022 28.7 32 UD 
16GP0025 36.3 32 UD 
16GP0051 32 32 UD 
16GP0058 27.8 32 UD 
16GP0173 18.8 33.1 UD 
16GP0185 39.7 33.1 UD 
16GP0204 19.9 33.1 UD 
16GP0210 26.2 33.1 UD 
16GP0339 21.4 33.1 UD 
16GP0345 38.3 33.1 UD 
16GP0399 33.1 33.1 UD 
16GP0435 39.4 33.1 UD 
16GP0482 40 33.1 UD 
16GP0514 17 33.1 UD 
16GP0519 38 33.1 UD 
16GP0522 26 33.1 UD 
16GP0523 40 33.1 UD 
16GP0529 37.8 33.1 UD 
16GP0740 31.7 33.4 UD 
16GP0745 22.1 33.4 UD 
16GP1308 37.3 33.4 UD 
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Table 3.4 PCR value in RSV-positive samples 
Samples Mean STD 
RSV negative  UD* UD* 
RSV positive  30.2 8.1 
Positive Control 32.9 0.5 
















This analytical quantitative cross-sectional study on RSV prevalence and 
seasonality took part in five general hospitals and clinics in Kinshasa, Democratic 
Republic of Congo and aimed at determining the proportion of and seasonal factors 
influencing Respiratory Syncytial Virus in Kinshasa, capital province of DRC. Two 
hypotheses were raised; the first hypothesis stipulated that respiratory syncytial virus 
presence in Kinshasa, DRC could be affected by socio-demographic characteristics such 
as gender, age and also severity of infection including hospitalization and the second 
hypothesis stipulated that respiratory syncytial virus incidence could be different 
according to the rainy season and the dry season in Kinshasa province of the Democratic 
Republic of Congo. Both Hypotheses in this study were confirmed: RSV was mostly 
present during the rainy season and RSV was more prevalent in children age 0-2 years, 
more prevalent in women than in men and was more prevalent in SARI samples than in 
ILI samples.   
 
4.1. RSV prevalence  
In many countries there is a need for data on the presence of respiratory syncytial 
virus (Griffiths, et al, 2017). This study tackled the prevalence using the variables gender, 
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age, season and severity of infections. Statistical analysis using SPSS 25 was used to 
determine the association between the variables and the outcome which was rRt-PCR 
detection of RSV and also the likelihood of RSV infection. This study showed that 
among inpatients and outpatients analyzed, 13.6% (N=23) was positive for RSV which 
was close to the prevalence of RSV findings in other countries such as the following 
countries in Africa: Kenya 17% (N=2050), South Africa 10.7% (N= 5743), Gambia 8.7% 
(N= 4799), Ghana 14.1% (N= 128), Mozambique 9.8% (N= 1172) and Burkina Faso 
11.9% (N= 209) (Bigogo, et al, 2013; Pretorius, et al, 2016; Weber, et al, 2002; Kwofie, 
et al, 2012; Fodha, et al, 2004; Ouédraogo, et al, 2014). In Madagascar, in an acute 
respiratory infection study done over one year the percentage of RSV positive was 11.8% 
(Hoffmann, et al 2012).  
These results can be representative of what is happening in the community of 
Kinshasa, DRC. Because of the small number of positives, the association between health 
facilities and RSV incidence was not checked nor taken in consideration. 
 
4.2 Gender 
In this study RSV was more prevalent in female than in male and at the same time 
it showed that females are more likely to be negative for RSV in Kinshasa. Other studies 
have shown that RSV was more predominant in male than in female whereby male were 
more affected (Glezen, 1977). The difference in findings from other studies could be due 
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to the fact that more female than male were part of this study population. Moreover the 
statistical analysis showed that there was no statistically significant association between 
gender and the presence of RSV which correlated with many other studies around the 
world whereby RSV is more prevalent in one gender but the finding is not statistically 
significant (Salimi, et al, 2015; Rahman, et al, 2014). Many studies also failed to show or 
find a direct association between gender and RSV infection (Dearden, et al, 2018). 
 
4.3. Age 
When it comes to age distribution of RSV, the virus occurrence and prevalence 
have demonstrated to be the same in all countries; it shows similarity in developed 
countries as well as developing countries (Glezen, et al, 1981; Glezen & Denny, 1973).  
Nolan et al, 2015 found in her study on the prevalence of RSV that RSV 
prevalence declined as age decreased and that finding was the same in this study as the 
RSV positive samples were the least in adults and children older than 5 years of age and 
was more prevalent in children at the age of 2 and/or younger than 2 years. This study on 
RSV in Kinshasa had 18 positives in children age 0-2, 1 RSV positive in children 5-10, 2 
RSV positive in age 10 to 25, and 2 RSV positive in age 40 and above which includes the 
elderly.   
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The findings from this study on RSV in Kinshasa is similar to many studies 
whereby children under the age of 2 were less likely to be negative for RSV and had 
higher risks and chances of being infected by RSV, a few cases of RSV positives in 
elderly were found in this study which also goes along with most reviews that also found 
sporadic cases of RSV infections in elderly. It is safe to say that the findings from this 
study correlated with many reviews and papers that looked at the association between age 
and RSV because this study also found a strong association p< 0.001 between age and 
RSV incidence in Kinshasa, DRC.  
 
4.5. RSV by case severity SARI and ILI  
Although this study findings showed that RSV was more present in samples of 
patients hospitalized with severe acute respiratory infection (60.9%) and less present in 
samples from patients that had influenza-like illness (39.1%) and that SARI patients are 
less likely to be negative for RSV, the statistical analysis showed that there was no 
statistically significant association between the severity of the infection and the presence 
or incidence of RSV.  
This finding goes hand in hand with other literatures and studies done to find if 
there was an association between acute respiratory infection and RSV presence 
(Singleton, et al, 2010; Ouédraogo, et al, 2014; Al-Ayed, et al., 2014). However, in a 
study on the prevalence of acute respiratory infection caused by RSV, findings showed 
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that there was an independent association between RSV and the risk of developing an 
acute respiratory infection, but this specific study only included children younger than the 
age of 5 years old, had a larger number of study sample and was done on a shorter period 
of time (5 months), those differences could have favoured the difference in findings from 
that study and this study on RSV in Kinshasa (Kabego, et al, 2018). 
 
4.6. Seasonality 
Respiratory syncytial virus has shown to have seasonal outbreaks in many 
countries around the world, in countries with mediterranean and temperate climate, RSV 
occurs during the relatively cold seasons, and in countries with tropical climates it occurs 
during the wet rainy season (Weber, et al, 1998). Studies have shown that seasonal RSV 
occurred in phases where there was a shorter phase of seasonal RSV infection and a 
longer phase of seasonal RSV infection (Elena, et al, 2005).    
The Democratic Republic of Congo is a very large country, second largest in 
Africa after Algeria and is passed through by the Equator line; the country has a 
predominantly tropical climate with two rainy season peak that can go up to seven 
months (World Bank, 2007). Parts of  DRC that are located on the north of the country 
experience wet rainy season from the month of April to the month of November, 
wherever the regions located on the south of DRC experience rainy season from October 
to May. The province of Kinshasa from which the samples were collected is located on 
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the south bank of DRC therefore experiences rainy season from October to May and dry 
season from June to September. The rainy season is relatively hot, wet and humid 
whereby the dry season is less hot and a tad cold and is considered the "cold season" with 
temperatures dropping to 20˚C and 17˚C at its lowest (Burton, 2010). 
This study in Kinshasa, DRC showed that RSV occurred predominantly 95.7% 
during the rainy season, which goes in accordance with most study findings on RSV 
seasonality for tropical climates. RSV incidence in this study decreased together with the 
temperature meaning the colder it got, the less RSV incidence occurred and this too was 
found in studies done in countries with similar climate to that of DRC. The cold or dry 
season in Kinshasa, DRC is holiday time and for 3 months straight all schools are closed, 
this can partially explain the decrease in RSV incidence as there might be lesser chances 
of contamination between children during that time since they do not attend school. 
 
4.7. Study Strengths and limitations 
4.7.1 Study Strengths 
This study is the first study done in Kinshasa DRC that gives a picture on the 
proportion of RSV in Kinshasa DRC and the first ever study done that studies the 
seasonal factors influencing the presence of RSV in the country at a community level 
based representation. This study used PCR laboratory detection to screen for RSV which 
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is one of the gold standards for detection of RSV around the world. This study may 
contribute in the future in implementation of preventive measures in the country, 
educational campaigns on RSV, increase knowledge on RSV, estimating public health 
burden on the community and health system due to RSV infections, stating the needs for 
proper equipment and resources for management of RSV infections and allocation of 
those resources. The results from this study done on RSV in Kinshasa, DRC correlated 
with many studies and reviews done and published on RSV globally. 
 
4.7.2 Study Limitations 
The study population was randomly chosen but not randomized from the Influenza 
sentinel sites, so it represents the community of Kinshasa but could be argued to represent 
the entire population of Kinshasa. The sample used for this study were from the year 
2016 which due to funding cessation only ran from January 2016 to September 2016 
therefore when it comes to seasonality, there is a limitation due to the missing remaining 
months of October, November and December.  
Seasonality studies are advised to go on for a longer period of time therefore 
strongly suggesting more studies and more researches to properly represent RSV 
seasonality in the country. And another point is DRC is the second largest country in 
Africa after Algeria and is passed through by the equator making the country fall into 2 
different climatic regions, however seasonal factors and influences found in this study 
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only applies to Southern part of DRC where Kinshasa is found and can not apply to the 
entire country, therefore studies need to be done in both climatic regions of DRC to 
represent each one accordingly. Furthermore this study on RSV in Kinshasa is limited to 
the tropical climate region where Kinshasa falls whereby the rainy season goes from 
October to May and the cold dry season goes from June to September meaning the 
findings from this study only represent one climate region and not the all territory of 
DRC.  
Lastly, this study did not look into the incidence of the subtypes of RSV which 
requires more time, funding, resources and equipment.  
 
4.8 Recommendations 
Further researches should be done on a much larger population and on a 
randomized population based study for the prevalence of RSV in the entire country. In 
addition, a study that covers many years should be done for an accurate and better 
representation of seasonality of RSV in all climate regions of DRC to represent the entire 
country. Research on RSV subtypes circulating in the country, association with risk 
factors as well as defining the risk factors in DRC for RSV should be done to help in the 
future with the prevention of RSV infections in DRC. A study on the burden of RSV in 
DRC including financial impact is recommended since burden of disease is important to 
know in public health and in any given country because it provides estimates on that 
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disease by providing information about the disease and health information which are 
respectively important for the prevention and control of any health condition, for 
resources’ allocation, for estimation of intervention’s cost when needed and lastly to 

















This analytical quantitative cross-sectional study on the seasonality and prevalence 
of respiratory syncytial viruses in Kinshasa, DRC aimed to investigate the proportion of 
RSV and seasonal factors influencing RSV in Kinshasa, DRC at community level. The 
objectives were to give the prevalence of the virus and give a picture on the seasonality of 
the virus in Kinshasa which is the capital city of DRC by analyzing nasopharyngeal 
samples from inpatients and outpatients of 5 sentinel sites in Kinshasa collected from 
January to September 2016 and analyzed using PCR in the NIRL at the INRB.   
After analysis of the samples, interpretation of the results as well as statistical 
analysis and interpretation, the results obtained from this research study showed that RSV 
infection occurs at most during the rainy season in Kinshasa, DRC with over 90% of RSV 
positive sample found in the rainy season and whereby people are less likely to develop 
an RSV infection during the dry season. A peak in RSV infection was observed between 
January and March 2016. This research study also revealed that children are the most 
infected by RSV in Kinshasa, DRC and that the virus was more predominant in children 
younger than 2 years and the same age range was found to be more likely to suffer from 
an RSV infection. Female in this study were the most infected by RSV compared to male, 
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